Pierre Fabre, which employs 11,000 worldwide, focuses its research and development on four therapeutic areas: oncology, dermatology, the central nervous system and consumer health care.

It has always formed partnerships within France and internationally with public research institutions, faculties and universities, along with pharma companies, including Allergan and AbbVie, and biotechs.